-
Tangibly Launches Trade Secret Consulting Services
SEATTLE, May 6, 2024 /PRNewswire/ — Tangibly, Inc., the leading SaaS trade secret management platform, today announced the launch of its consulting services offering. Designed to complement its trade secret software, the services are in response from customer feedback and requests for more personalized bespoke engagements with Tangibly specialists. Trade secrets continue to gain attention
-
Ingenium Therapeutics Novel NK Cell Therapy Receives Orphan Drug Designation From FDA
Breakthrough Technology Empowers NK Cell Therapy for Acute Myeloid Leukemia DAEJEON, Korea, April 30, 2024 /PRNewswire/ — Ingenium Therapeutics, a leading innovator in next-generation NK cell therapies, announced today that its investigational therapy IGNK001 (Gengluecel) has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of acute myeloid
-
Journal of Pharmaceutical Analysis Articles Reveal the Importance of Phytocompounds and Metabolomics Analysis
Researchers address drug-related toxicity in chemotherapy and explore alternatives from traditional Chinese medicine to treat diabetic neuropathy XI’AN, China, April 30, 2024 /PRNewswire/ — Inflammatory bowel disease (IBD) is a common chronic gastrointestinal disorder and current treatment strategies can cause adverse effects. Thus, there is a need to identify alternative compounds to treat IBD. Similarly,
-
COEUS Solutions Rebrands as BridgeView Life Sciences After Successful Spinoff
Company eyes global expansion and introduction of new solutions for life sciences industry’s most pressing challenges PAOLI, Pa., April 30, 2024 /PRNewswire/ — COEUS Solutions, a leading provider of innovative technologies and services in the life sciences industry, today announces its rebranding to BridgeView Life Sciences (“BridgeView”) following a recent spinoff from its former parent
-
Single Pass, Inc. Announces FDA Clearance of its Kronos Biopsy Closure Device
LAKE FOREST, Calif., April 29, 2024 /PRNewswire/ — Single Pass, Inc. is proud to announce that its Class II Kronos biopsy closure device has received clearance from the U.S. Food and Drug Administration (FDA). The FDA has determined the device is substantially equivalent to predicate devices regarding its safety and effectiveness. Continue Reading The Single Pass
-
Heart-Valve-Surgery.Com and Medtronic Launch Novel “Aortic Stenosis Patient Activation Platform” to Empower Patients
LOS ANGELES, April 25, 2024 /PRNewswire/ — Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from Medtronic, a global leader in healthcare technology, today launched the “Aortic Stenosis Patient Activation Platform”, an end-to-end digital platform for patient awareness, patient education, and patient activation specific to aortic valve stenosis. Continue Reading Aortic Valve
-
GenEmbryomics and Progenesis Announce Strategic Partnership to Transform IVF Testing
MELBOURNE, Australia and LA JOLLA, Calif., April 24, 2024 /PRNewswire/ — In a move that is set to transform clinical reproductive medicine, GenEmbryomics Limited, a pioneering provider of advanced genetic testing services for embryos, and Progenesis Inc, a leading provider of preimplantation genetic testing for in vitro fertilization (IVF), today announced a groundbreaking collaboration to
-
RTI International and Nested Knowledge Announce Collaboration to Enhance Life Science and Healthcare Research
Strategic collaboration follows RTI’s equity investment in the technology start-up RESEARCH TRIANGLE PARK, N.C., April 24, 2024 /PRNewswire/ — RTI International, a nonprofit research institute, and Nested Knowledge, a platform for AI-driven evidence synthesis, systematic literature review and meta-analysis, formally announce a strategic collaboration between the two organizations. The Collaboration Agreement will provide clients with
-
Penstock Partners with Paradigm to Lower Unnecessary Spend on Surgical Implants
WILLIAMSVILLE, N.Y., April 23, 2024 /PRNewswire/ — Penstock Group announced today a partnership with Paradigm, an accountable specialty care management organization and developer of a proprietary payment integrity program assuring accurate payments for surgical implant claims. Penstock, a leader in the healthcare payment integrity space focused on delivering innovative and niche results, saw a unique opportunity to
-
Clinical Microbiomics Launches Advanced Long-Read 16S, ITS, 18S, Isolate, and Metagenomics Sequencing Services
Offering Unparalleled Resolution and Quality in Microbial Analysis COPENHAGEN, Denmark, April 23, 2024 /PRNewswire/ — Clinical Microbiomics, a leader in microbiome analysis, announces the launch of its advanced long-read sequencing services. Tailored to meet the stringent requirements of academic, clinical, and industrial researchers, the expanded offerings deliver unmatched insights into microbial communities, featuring the industry’s highest
